CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ROMANIA – MENTOR STUDY

MENTOR STUDY

  • Cristian Serafinceanu Clinic of Diabetes, Carol Davila University of Medicine and Pharmacy, National Institute for Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania
  • Viviana Iulia Elian Clinic of Diabetes, Carol Davila University of Medicine and Pharmacy, National Institute for Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania
  • Doina Catrinoiu Diabetes, Nutrition and Metabolic Diseases, Ovidius University of Medicine and Pharmacy, Emergency Clinical Hospital, Constanta, Romania
  • Cristian Guja Clinic of Diabetes, Carol Davila University of Medicine and Pharmacy, National Institute for Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania
  • Bogdan Mihai Diabetes, Nutrition and Metabolic Diseases, Gr.T.Popa University of Medicine and PharmacyClinical Hospital “St. Spiridon” Iasi, Romania
  • Maria Mota University of Medicine and Pharmacy, Craiova, Romania
  • Gabriela Roman Iuliu Hatieganu University of Medicine and Pharmacy – Clinical Center of Diabetes, Nutrition, Metabolic Diseases, Cluj-Napoca, Romania
  • Romulus Timar Victor Babes University of Medicine and Pharmacy, Emergency Clinical Hospital, Timisoara, Romania
Keywords: Type 2 Diabetes Mellitus, Diabetes Complications, Romanian T2D management, T2D national data, Diabetes Treatment

Abstract

Background and aims: PREDATORR Study estimated diabetes mellitus(DM) prevalence at 11,7%. MENTOR is the first national major study trying to determine metabolic control of patients with type 2 diabetes(T2DM), the therapeutic options used, and the microvascular and macrovascular complications prevalence in order to achieve a better management for Romanian patients with T2DM.

Material and methods: The study was designed as an observational analytical, multicenter, prospective study. Study population was selected from T2DM patients stratified by: age, diabetes duration and gender. Data was collected in an eCRF: demographics, physical examination, cardiovascular evaluation, blood tests, known pathology, treatment.

Results: There were 54.80% women, mean age was 60.53±7.39 years. The average BMI is over 30 kg/m2 with a decreasing trend over the age. 60% had their HbA1c over the threshold of 7%. Average blood pressure was less than 140/80 mmHg. 76,66% of T2DM subjects have at least one chronic complication. On oral therapy we have 55.44% of patients, on insulin only therapy 12.99% and on a combination of oral and insulin therapy 22.51%.

Conclusions: This study showed a high prevalence of diabetes complications and metabolic alterations (obesity, hypertension, dyslipidemia, etc.). Age, male gender and diabetes duration were associated with a higher risk for poor metabolic control and complications. Further data will be collected over a 3 years period to obtain a better image over T2DM evolution in Romanian population.

Published
2018-12-22
Section
Original Research Articles